Literature DB >> 2013810

Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies.

A A Mejia1, T Nakamura, I Masatoshi, J Hatazawa, M Masaki, S Watanuki.   

Abstract

Radiation absorbed doses due to intravenous administration of fluorine-18-fluorodeoxyglucose in positron emission tomography (PET) studies were estimated in normal volunteers. The time-activity curves were obtained for seven human organs (brain, heart, kidney, liver, lung, pancreas, and spleen) by using dynamic PET scans and for bladder content by using a single detector. These time-activity curves were used for the calculation of the cumulative activity in these organs. Absorbed doses were calculated by the MIRD method using the absorbed dose per unit of cumulated activity, "S" value, transformed for the Japanese physique and the organ masses of the Japanese reference man. The bladder wall and the heart were the organs receiving higher doses of 1.2 x 10(-1) and 4.5 x 10(-2) mGy/MBq, respectively. The brain received a dose of 2.9 x 10(-2) mGy/MBq, and other organs received doses between 1.0 x 10(-2) and 3.0 x 10(-2) mGy/MBq. The effective dose equivalent was estimated to be 2.4 x 10(-2) mSv/MBq. These results were comparable to values of absorbed doses reported by other authors on the radiation dosimetry of this radiopharmaceutical.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013810

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

1.  An imaging co-registration system using novel non-invasive and non-radioactive external markers.

Authors:  Tung-Hsin Wu; Jiunn-Kuen Wang; Jason J S Lee; Ren-Shyan Liu; Wan-Yuo Guo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

2.  Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study.

Authors:  Akihiro Takano; Christer Halldin; Andrea Varrone; Per Karlsson; Nils Sjöholm; James B Stubbs; Magnus Schou; Anu J Airaksinen; Johannes Tauscher; Balázs Gulyás
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11-14       Impact factor: 9.236

3.  Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study.

Authors:  Akihiro Takano; Balázs Gulyás; Andrea Varrone; Per Karlsson; Nils Sjoholm; Stig Larsson; Cathrine Jonsson; Richard Odh; Richard Sparks; Nabil Al Tawil; Anja Hoffmann; Torsten Zimmermann; Andrea Thiele; Christer Halldin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-06       Impact factor: 9.236

4.  Estimation of organ biodistribution and absorbed dose from external measurement with TLDs in PET studies.

Authors:  M Matsumoto; T Nakamura; H Watabe; M Itoh; J Hatazawa
Journal:  Med Biol Eng Comput       Date:  1993-07       Impact factor: 2.602

5.  Estimation of kidneys and urinary bladder doses based on the region of interest in 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography examination: a preliminary study.

Authors:  Farida Aimi Mustapha; Farahnaz Ahmad Anwar Bashah; Ihsan M Yassin; Ahmad Saad Fathinul Fikri; Abdul Jalil Nordin; Hairil Rashmizal Abdul Razak
Journal:  Quant Imaging Med Surg       Date:  2017-06

6.  Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa).

Authors:  Romina Mizrahi; Pablo M Rusjan; Irina Vitcu; Alvina Ng; Alan A Wilson; Sylvain Houle; Peter M Bloomfield
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

7.  PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs).

Authors:  G J Meyer; S L Waters; H H Coenen; A Luxen; B Maziere; B Langström
Journal:  Eur J Nucl Med       Date:  1995-12

8.  3-O-methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging.

Authors:  B Beuthien-Baumann; J Bredow; W Burchert; F Füchtner; R Bergmann; H-D Alheit; G Reiss; R Hliscs; R Steinmeier; W-G Franke; B Johannsen; J Kotzerke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-24       Impact factor: 9.236

9.  Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[18F]Fluorobenzylguanidine: Biodistribution and Radiation Dosimetry.

Authors:  Stephen J Lokitz; Sudha Garg; Rachid Nazih; Pradeep K Garg
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

Review 10.  Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.

Authors:  Amy M Fowler; Amy S Clark; John A Katzenellenbogen; Hannah M Linden; Farrokh Dehdashti
Journal:  J Nucl Med       Date:  2016-02       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.